France Patient Monitoring Accessories Market Outlook to 2025

2018-12-01
Price :
Published : Dec-2018
No. of Pages : 33

France Patient Monitoring Accessories Market Outlook to 2025

Summary

GlobalData’s new report, France Patient Monitoring Accessories Market Outlook to 2025, provides key market data on the France Patient Monitoring Accessories market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments – Patient Monitoring Leads and Electrodes, Patient Monitoring Temperature Probes and Non-Invasive Blood Pressure Cuffs.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

– Market size and company share data for Patient Monitoring Accessories market segments – atient Monitoring Leads and Electrodes, Patient Monitoring Temperature Probes and Non-Invasive Blood Pressure Cuffs.
– Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
– 2017 company share and distribution share data for Patient Monitoring Accessories market.
– Global corporate-level profiles of key companies operating within the France Patient Monitoring Accessories market.
– Key players covered include 3M Health Care Ltd, Medtronic plc, Philips Healthcare, GE Healthcare LLC and others.

Reasons to buy

– Develop business strategies by identifying the key market categories poised for strong growth in the future.
– Develop market-entry and market expansion strategies.
– Design competition strategies by identifying who-stands-where in the market.
– Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
– What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Hepatitis B: Competitive Landscape to 2027

Hepatitis B: Competitive Landscape to 2027 Summary Hepatitis B is a viral infection of the liver that can become chronic in young children, especially newborns to mothers with HBV infections, and people with compromised immune systems. Chronic hepatitis B is defined as measurable Hepatitis surface antigen (HBsAg) levels for more than six months after an acute infection. Despite the existence of prophylactic vaccines, hepatitis B remains a global public health threat, with approximately 257 million people worldwide living with chronic HBV infections. Chronic hepatitis B cannot be cured and patients have elevated risks of developing liver cirrhosis and hepatocellular carcinoma (HCC). This report provides an assessment of the pipeline, clinical, and commercial landscape of Hepatitis B. Ov......
$3495

Pediatric Vaccines: Epidemiology Forecast to 2028

Pediatric Vaccines: Epidemiology Forecast to 2028 Summary The administration of a vaccine, referred to as vaccination, elicits an immune response that prevents an individual from developing a specific disease when exposed to the corresponding infectious agent in the future. A successful vaccination results in immunization, where the individual is deemed immune to the disease. Routine immunization programs aim to protect children at an early age, when they are the most vulnerable to disease. Prior to the discovery of vaccines, several infectious diseases claimed the lives of millions of children each year. GlobalData epidemiologists utilized comprehensive, country-specific vaccination rate data from nationally representative public health surveillance systems and databases to arrive at ......
$3995

Parkinson’s Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects Summary Parkinson's disease (PD), a progressive neurological disorder that affects movement control, is associated with considerable quality of life impairments and burden of care, particularly in the advanced disease stages. Cognitive and behavioral complications of PD are common. PD-associated dementia and PD-associated psychosis are both highly prevalent and associated with a large disease burden. There is a pressing unmet need within PD, PD-associated dementia, and PD-associated psychosis for more effective disease-modifying pharmacotherapies. Although current therapies can provide patients with symptomatic relie......
$6995

Obesity: Gut Hormone Receptors Retain Commercial Prominence

Obesity: Gut Hormone Receptors Retain Commercial Prominence Summary Obesity is a chronic and potentially fatal disease. The most prevalent metabolic disorder affecting people today, obesity requires multidisciplinary continuing treatment. Despite the market's clinical and regulatory challenges, the obesity pipeline is robust and contains a high level of diversity in both molecule types and molecular targets, which is in line with its multifactorial etiology. The primary concern within the market is the need for medications that adequately address the unmet clinical needs in the overweight and obese population, namely efficacious and safe therapies. This report assesses first-in-class innovation across the obesity pipeline. Scope - The obesity pipeline is robust and contains a high leve......
$6995

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end......
$2500

Constipation Global Clinical Trials Review, H1, 2019

Constipation Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Constipation Global Clinical Trials Review, H1, 2019" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500

Circadian Rhythm Sleep Disorders Global Clinical Trials Review, H1, 2019

Circadian Rhythm Sleep Disorders Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Circadian Rhythm Sleep Disorders Global Clinical Trials Review, H1, 2019" provides an overview of Circadian Rhythm Sleep Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Circadian Rhythm Sleep Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDa......
$2500

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprie......
$2500

Colonic Diverticulitis Global Clinical Trials Review, H1, 2019

Colonic Diverticulitis Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Colonic Diverticulitis Global Clinical Trials Review, H1, 2019" provides an overview of Colonic Diverticulitis clinical trials scenario. This report provides top line data relating to the clinical trials on Colonic Diverticulitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrac......
$2500

Chronic Heart Failure Global Clinical Trials Review, H1, 2019

Chronic Heart Failure Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Chronic Heart Failure Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Cl......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy